. Author manuscript; available in PMC: 2022 Apr 11.

Published in final edited form as: Ann Behav Med. 2012 Feb;43(1):62–73. doi: 10.1007/s12160-011-9319-4

Table 2.

Change in the primary and secondary outcomes from baseline to the end of the intervention period (month 8) within and between groups

Variables	Within-group change scores from baseline to the end of intervention		Difference in change scores between groups

	Automated telephone intervention (n =169)	Control (n=168)

Primary outcomes^d
Overall diet quality score	2.8	−0.74	3.54^*
MOD+PA^a (min/week)	−3.44	2.77	−6.21
>150 min/week MOD+PA (%)	−2	5	7
Total energy expenditure (kcal/day)	43.8	−36.2	80.0^*
Medication Adherence Score^b	0.45	0.26	0.19
Secondary outcomes^d
Systolic blood pressure (mmHg)	−2.06	0.25	−2.31
Achieved control^c (%)	0.7	1.9	−1.2
Diastolic blood pressure (mmHg)	−1.28	−0.1	−1.18
Achieved control^c (%)	6.4	5.1	1.3
Achieved control of both systolic and diastolic blood pressure (%)	5.8	5.0	0.8

p<0.05

Mod+PA—moderate-or-greater intensity leisure time physical activity

From the 7-item version of the 8-item Morisky Medication Adherence Scale [13]

Systolic blood pressure control defined as <140 mmHg (<130 mmHg if diabetic). Diastolic blood pressure control defined as <90 mmHg (<80 mmHg if diabetic)

Means and proportions are adjusted for covariates used in the specific regression model (see text)